TY  - JOUR
AU  - Matamoros Felipe, José Antonio
AU  - Rubio Casado, Sara
AU  - Fernández Albarral, José
AU  - Martínez López, Miguel Ángel
AU  - Ramírez, Ana I.
AU  - García Martín, Elena Salobrar
AU  - Marco López, Eva M. 
AU  - Paleo García, Víctor
AU  - Hoz Montañana, María Rosa De
AU  - López Cuenca, Inés
AU  - ElviraHurtado, Lorena
AU  - Sánchez-Puebla Fernández, Lidia
AU  - Ramírez Sebastián, José Manuel
AU  - López Gallardo, Meritxell
AU  - Salazar, Juan J.
PY  - 2025
DO  - 10.3390/ph18050694
UR  - https://hdl.handle.net/20.500.14352/120091
T2  - Pharmaceuticals
AB  - Background/Objectives: The loss of retinal ganglion cells (RGCs) is a hallmark of glaucoma, a major cause of blindness. Glial cell activation due to increased intraocular pressure (IOP) significantly contributes to RGC death. Therefore, substances...
LA  - eng
PB  - MDPI
KW  - Ocular hypertension
KW  - Retina
KW  - Visual pathway
KW  - Glial cells
KW  - Citicoline
KW  - Coenzyme Q10
KW  - Glaucoma
TI  - Citicoline and Coenzyme Q10: Therapeutic Agents for Glial Activation Reduction in Ocular Hypertension
TY  - journal article
VL  - 18
ER  -